Invest in Manna Corp

Medical strategies for better, simpler health.

Join us in transforming the future of cancer care through affordable, MHC-directed immunotherapy.
Our mission is simple: bring life-saving innovation to patients — quickly, ethically, and affordably.

The Problem

85% of cancer patients don’t respond to existing immunotherapies.
1 in 3 oncologists report they can’t access life-saving information in time to guide care.
75% of online cancer content contains harmful or misleading data.
Meanwhile, new “breakthroughs” often fall short—leaving patients behind.

Our Solution

We’ve developed a therapeutic peptide immunotherapy that targets changes in MHC expression to restore immune recognition of cancer cells.

Tumor-agnostic platform
14-day turnaround
Up to 800% more affordable
Lower toxicity, greater precision
Backed by conservative, high-confidence financial modeling

But Manna is more than a treatment—it’s an ecosystem:

A HIPAA-compliant app for provider-patient connection (currently in development), click to view Mockup
A podcast combating misinformation and building trust
An online Academy offering accredited education to oncology professionals

What We're Looking For

Manna Corp is actively building/affirming strategic partnerships with:

Investors ready to support high-impact biotech, click to view our Pitch Deck or Schedule a Call to learn more.
Providers who value transparency, safety, and personalization, click to view our Platform or Academy.
Patient advocates who believe in faster access to-life saving care, click to view our Podcast.
Government allies to help remove barriers to treatment, click to Schedule a Call or view our Platform.

Get Involved

📄 Read Our White Paper – Dive into the science, strategy & ROI

📆 Schedule a Conversation – Meet our leadership team

🧭 Explore the Ecosystem – See our platform, Academy & podcast